| Q4 Net Sales | $1.67B, +5% YoY | CFO |
| Q4 Comparable Sales Change | +1% (incl. ~100bps FX benefit) | CFO |
| Q4 Operating Margin | 14.1% | CFO |
| Q4 Adjusted EBITDA Margin | 16.6% ($276M) | CFO |
| Q4 EPS (diluted) | $3.68 | CFO |
| FY2025 Net Sales | $5.27B, +6% YoY | CFO |
| FY2025 Operating Margin (adj.) | 12.5% | CFO |
| FY2025 Adjusted EBITDA Margin | 15.5% ($816M) | CFO |
| FY2025 EPS (diluted, adj.) | $9.86 | CFO |
| FY2025 Operating Cash Flow | $600M | CFO |
| FY2025 Free Cash Flow | $378M | CFO |
| FY2025 Share Repurchases | $450M (5.4M shares, 11% of start-of-year shares) | CFO |
| Q4 Inventory (cost) | +5% YoY | CFO |
| FY2026E Net Sales Growth | 3%-5% | CFO |
| FY2026E Operating Margin | 12%-12.5% | CFO |
| FY2026E EPS | $10.20-$11.00 | CFO |
| FY2026E CapEx | $200M-$225M | CFO |
| FY2026E Share Repurchases | ~$450M | CFO |
| Q1 2026E Net Sales Growth | 1%-3% | CFO |
| Q1 2026E Operating Margin | ~7% | CFO |
| Q1 2026E EPS | $1.20-$1.30 | CFO |